½ÃÀ庸°í¼­
»óǰÄÚµå
1741254

Äܵå·ÎÀÌÆ¾ Ȳ»ê ½ÃÀå : °ø±Þ¿øº°, Áö¿ªº°

Chondroitin Sulfate Market, By Source, and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Äܵå·ÎÀÌÆ¾ Ȳ»ê ½ÃÀåÀº 2025³â¿¡´Â 13¾ï 2,760¸¸ ´Þ·¯, 2032³â¿¡´Â 16¾ï 4,390¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ°í, 2025-2032³â±îÁöÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 3.1%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 13¾ï 2,760¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ : 2025-2032³â CAGR 3.10% 2032³â ±Ý¾× ¿¹Ãø 16¾ï 4,390¸¸ ´Þ·¯

Äܵå·ÎÀÌÆ¾ Ȳ»êÀº °Ç°­ÇÑ ¿¬°ñ, »À, °áÇÕ Á¶Á÷ÀÇ ÃËÁø¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â Áß¿äÇÑ ºÐÀÚÀÔ´Ï´Ù. ÀÌ Áúº´ÀÇ ¹ß»ýÀº ³ëÈ­, À¯Àü, ½Ä»ýȰÀÇ È¥¶õ, ºñ¸¸ µî ¿©·¯ ¿äÀÎÀÌ °ü·ÃµÇ¾î ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

¼¼°èÀÇ Äܵå·ÎÀÌÆ¾ Ȳ»ê ½ÃÀåÀº ¿µ¾ç º¸Á¶ ½Äǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ µû¶ó ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. °ßÀÎÇÏ´Â ¶Ç ´Ù¸¥ ¿äÀÎÀº ¾È±¸°ÇÁ¶ÁõÀÇ Ä¡·á¿¡ µµ¿òÀÌ µÇ´Â ¾È¾àÀÇ ¼ººÐÀ¸·Î¼­ Äܵå·ÎÀÌÆ¾ Ȳ»ê¿°ÀÇ »ç¿ëÀÌ Áõ°¡Çϰí ÀÖ´Â °ÍÀÔ´Ï´Ù. ¶ÇÇÑ, ¼ºÀåÀ» °¡¼ÓÇÏ°í ½ºÆ®·¹½º¸¦ °æ°¨Çϱâ À§ÇØ, µ¿¹°»ç·á¿¡ÀÇ Ã·°¡¹°·Î¼­µµ ÀϹÝÀûÀÔ´Ï´Ù.

¹Ý¸é ¿ø·á °¡°Ý º¯µ¿Àº ½ÃÀå ¼ºÀåÀ» Á¦ÇÑÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • º» º¸°í¼­¿¡¼­´Â ¼¼°èÀÇ Äܵå·ÎÀÌÆ¾ Ȳ»ê ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2024³âÀ» ±âÁØ¿¬µµ·Î ÇÑ ¿¹Ãø±â°£ 2025-2032³â ½ÃÀå ±Ô¸ð¿Í º¹ÇÕ¿¬°£ ¼ºÀå·ü(CAGR%)À» Á¦°øÇÕ´Ï´Ù.
  • ¶Ç, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ±âȸ¸¦ ¹àÇô, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾ÈÀÇ ¸ÅÆ®¸¯½º¿¡ ´ëÇØ¼­ ÇØ¼³Çß½À´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç°ÀÇ »ó½Ã³ª ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ª¿¡ ÀÇÇÑ Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ Áß¿äÇÑ °íÂûµµ Á¦°øÇÕ´Ï´Ù.
  • ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ½ÇÀû, Àü·« µîÀÇ ÆÄ¶ó¹ÌÅÍ¿¡ ±Ù°ÅÇØ, ¼¼°èÀÇ Äܵå·ÎÀÌÆ¾ Ȳ»ê ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» Á¦°øÇÕ´Ï´Ù.
  • º» º¸°í¼­·ÎºÎÅÍ ÅëÂû¿¡ ÀÇÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ³ª ±â¾÷ÀÇ °æ¿µÁøÀº Àå·¡ÀÇ Á¦Ç° ¹ß¸Å, À¯Çü ¾÷, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ °üÇÑ Á¤º¸¿¡ ±Ù°ÅÇÑ ÀÇ»ç °áÁ¤À» ½Ç½ÃÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • Äܵå·ÎÀÌÆ¾ Ȳ»ê ¼¼°è ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë ¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µîÀÌ »ê¾÷ÀÇ ´Ù¾çÇÑ ÀÌÇØ °ü°èÀÚ¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù.
  • ÀÌÇØ °ü°èÀÚ´Â ¼¼°èÀÇ Äܵå·ÎÀÌÆ¾ Ȳ»ê ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç °áÁ¤ÀÌ ¿ëÀÌÇØÁý´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map (COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • °ñ°üÀý¿°ÀÇ À¯º´·ü Áõ°¡
    • ¿ø·á °¡°ÝÀÇ º¯µ¿
    • È®´ëÇÏ´Â Á¦¾à»ê¾÷
  • ¿µÇ⠺м®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Ç° Ãâ½Ã/½ÂÀÎ
  • PEST ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • ÇÕº´°ú Àμö ½Ã³ª¸®¿À

Á¦4Àå ¼¼°èÀÇ Äܵå·ÎÀÌÆ¾ Ȳ»ê ½ÃÀå, Äڷγª ¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • COVID-19 ¿ªÇÐ
  • °ø±ÞÃø°ú ¼ö¿äÃøÀÇ ºÐ¼®
  • °æÁ¦¿¡ ¹ÌÄ¡´Â ¿µÇâ

Á¦5Àå ¼¼°èÀÇ Äܵå·ÎÀÌÆ¾ Ȳ»ê ½ÃÀå, °ø±Þ¿øº°, 2020-2032³â

  • ¼Ò°³
  • ¼Ò
  • ¿µ¾çº¸Á¶½Äǰ
  • ÀǾàǰ
  • µ¿¹°»ç·á
  • ÆÛ½º³ÎÄɾî&È­Àåǰ
  • ±âŸ
  • µÅÁö
  • ¿µ¾çº¸Á¶½Äǰ
  • ÀǾàǰ
  • µ¿¹°»ç·á
  • ÆÛ½º³ÎÄɾî&È­Àåǰ
  • ±âŸ
  • °¡±Ý
  • »ó¾î
  • ÇÕ¼º

Á¦6Àå ¼¼°èÀÇ Äܵå·ÎÀÌÆ¾ Ȳ»ê ½ÃÀå, Áö¿ªº°, 2020-2032³â

  • ¼Ò°³
  • ºÏ¹Ì
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áß³²¹Ì
  • Áßµ¿
  • ¾ÆÇÁ¸®Ä«

Á¦7Àå °æÀï ±¸µµ

  • TSI Group Ltd.
  • Qingdao Wan Toulmin Biological Products Co., Ltd
  • HeBei SanXin Industrial Group
  • Bioiberica SAU
  • Sigma-Aldrich, Inc.
  • Sino Siam BIoTechnique Company Limited
  • Bio-gen Extracts Private Limited
  • SEIKAGAKU CORPORATION
  • BRF
  • ZPD

Á¦8Àå ¼½¼Ç

  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç¿¡ ´ëÇØ
SHW 25.06.17

Chondroitin Sulfate Market is estimated to be valued at USD 1,327.6 Mn in 2025 and is expected to reach USD 1,643.9 Mn by 2032, growing at a compound annual growth rate (CAGR) of 3.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 1,327.6 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 3.10% 2032 Value Projection: USD 1,643.9 Mn

Chondroitin sulfate is an important molecule that plays a key role in promoting healthy cartilage, bones, and connective tissues. It is used in the treatment of various skeletal conditions, such as osteoarthritis. Osteoarthritis is a painful condition, which leads to inflammation and stiffness of joints. Several factors are responsible for the emergence of the disease, including age, genetics, poor diet, and obesity. Chondroitin sulfate is widely used as a natural remedy to treat osteoarthritis. Moreover, it also acts as an anti-inflammatory agent.

Market Dynamics:

The global chondroitin sulfate market is growing on the account of increasing demand for dietary supplements. This is mainly due to the increase in the aging population, which makes them more susceptible to bone-related diseases such as osteoarthritis. Another factor driving the market is the growing use of chondroitin sulfate as an ingredient in eye drops, which helps in treating dry eyes. In addition, it is a common additive in animal feed to enhance growth and reduce stress.

On the other hand, fluctuating price of raw materials is expected to restrict the market growth.

Key features of the study:

  • This report provides in-depth analysis of the global chondroitin sulfate market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global chondroitin sulfate market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include TSI Group Ltd., Qingdao Wan Toulmin Biological Products Co., Ltd, HeBei SanXin Industrial Group, Bioiberica S.A.U., Sigma-Aldrich, Inc., Sino Siam Biotechnique Company Limited, Bio-gen Extracts Private Limited, SEIKAGAKU CORPORATION, BRF, and ZPD
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global chondroitin sulfate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global chondroitin sulfate market

Detailed Segmentation:

  • Global Chondroitin Sulfate Market, By Source
    • Bovine
    • Nutraceuticals
    • Pharmaceuticals
    • Animal Feed
    • Personal Care & Cosmetics
    • Others
    • Swine
    • Nutraceuticals
    • Pharmaceuticals
    • Animal Feed
    • Personal Care & Cosmetics
    • Others
    • Poultry
    • Shark
    • Synthetic
  • Global Chondroitin Sulfate Market, By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • TSI Group Ltd.
    • Qingdao Wan Toulmin Biological Products Co., Ltd
    • HeBei SanXin Industrial Group
    • Bioiberica S.A.U.
    • Sigma-Aldrich, Inc.
    • Sino Siam Biotechnique Company Limited
    • Bio-gen Extracts Private Limited
    • SEIKAGAKU CORPORATION
    • BRF
    • ZPD

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Source
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Growing prevalence of osteoarthritis
    • Volatile price of raw materials
    • Expanding pharmaceutical industry
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Chondroitin Sulfate Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Chondroitin Sulfate Market, By Source, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Bovine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Nutraceuticals
  • Pharmaceuticals
  • Animal Feed
  • Personal Care & Cosmetics
  • Others
  • Swine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Nutraceuticals
  • Pharmaceuticals
  • Animal Feed
  • Personal Care & Cosmetics
  • Others
  • Poultry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Shark
  • Synthetic

6. Global Chondroitin Sulfate Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2020-2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
  • Central and South America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)

7. Competitive Landscape

  • TSI Group Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Qingdao Wan Toulmin Biological Products Co., Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • HeBei SanXin Industrial Group
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bioiberica S.A.U.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sigma-Aldrich, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sino Siam Biotechnique Company Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bio-gen Extracts Private Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • SEIKAGAKU CORPORATION
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BRF
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • ZPD
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

8. Section

  • Research Methodology
  • About us
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦